EUVIMEDEUVIMED entdecken
Crossref

A Novel Polarity Switching LC‐MS/MS Method for Simultaneous Quantification of Drospirenone and Estetrol: Application to Pharmacokinetic Studies in Human Plasma

Pravesh Singh iD, Sajad Khaliq Dar iD, Faisal Hamid Khan iD, Asjad Nabi Khan Sherwani, Sanjay Jagannath Gurule, Onkar Singh, Sudershan Kumar iD, Arshad H Khuroo iD

Biomedical Chromatography · 2026

DOI: 10.1002/bmc.70633 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Chromatography, 2026. Verfasst von Pravesh Singh und 7 weiteren Autor:innen. Beteiligte Einrichtung: Sun Pharmaceutical Industries Limited, Mumbai, India. Hauptthemen laut MEDLINE: Androstenes, Tandem Mass Spectrometry, Liquid Chromatography-Mass Spectrometry. Die Arbeit nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A sensitive, selective, and rapid liquid chromatography–tandem mass spectrometry (LC‐MS/MS) method using a polarity switch technique was developed and validated for the simultaneous determination of drospirenone (DSP) and estetrol (E4) in human plasma for the first time. Solid phase extraction (SPE) with Bond Elut PLEXA cartridges was performed. Chromatographic separation was obtained on Eclipse XDB‐C8 (150 mm × 4.6 mm, 3.5 μm) column using 2‐mM ammonium bicarbonate solution:methanol (30:70, v / v ) as the mobile phase at a flow rate of 0.750 mL/min. A polarity switching method was performed in a triple quadrupole mass spectrometer using multiple reaction monitoring (MRM). MRM was performed in positive mode for DSP transitions m / z 367.2 → 171.1 and DSP‐D4 transitions m / z 371.2 → 171.1, and in negative mode for E4 transitions m / z 303.1 → 241.2, 273.0 and E4‐d3 transitions m / z 306.2 → 243.2, 275.0. Calibration curves were linear over the concentration ranges of 0.351–100.446 and 0.351–50.134 ng/mL for DSP and E4, respectively. The accuracy measured for both analytes ranged from −2.74% to 4.21%. Both the analytes showed consistent recoveries ranged from 77.25% to 81.34% with no significant matrix effect. The method was successfully applied in a pharmacokinetic study of DSP and E4 tablets (3 mg + 14.2 mg).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AndrostenesTandem Mass SpectrometryLiquid Chromatography-Mass SpectrometryHumansReproducibility of ResultsLinear ModelsLimit of DetectionSolid Phase ExtractionSensitivity and Specificity

Stichwörter der Autor:innen

SPEdrospirenoneestetrolmatrix effectpolarity switchingquality controlselectivity

Substanzen

Androstenesdrospirenone

Autor:innen und Institutionen

  • Sun Pharmaceutical Industries Limited, Mumbai, India.

ORCID-Profile: Pravesh Singh, Sajad Khaliq Dar, Faisal Hamid Khan, Sudershan Kumar, Arshad H Khuroo

Zitieren

APA

Singh, P., Dar, S. K., Khan, F. H., Sherwani, A. N. K., Gurule, S. J., Singh, O., Kumar, S., & Khuroo, A. H. (2026). A Novel Polarity Switching LC‐MS/MS Method for Simultaneous Quantification of Drospirenone and Estetrol: Application to Pharmacokinetic Studies in Human Plasma. Biomedical Chromatography. https://doi.org/10.1002/bmc.70633

Vancouver

Singh P, Dar SK, Khan FH, Sherwani ANK, Gurule SJ, Singh O, et al. A Novel Polarity Switching LC‐MS/MS Method for Simultaneous Quantification of Drospirenone and Estetrol: Application to Pharmacokinetic Studies in Human Plasma. Biomedical Chromatography. 2026. doi:10.1002/bmc.70633

BibTeX
@article{Singh2026,
  author = {Singh, Pravesh and Dar, Sajad Khaliq and Khan, Faisal Hamid and Sherwani, Asjad Nabi Khan and Gurule, Sanjay Jagannath and Singh, Onkar and Kumar, Sudershan and Khuroo, Arshad H},
  title = {A Novel Polarity Switching LC‐MS/MS Method for Simultaneous Quantification of Drospirenone and Estetrol: Application to Pharmacokinetic Studies in Human Plasma},
  journal = {Biomedical Chromatography},
  year = {2026},
  doi = {10.1002/bmc.70633}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche